<DOC>
	<DOC>NCT00236301</DOC>
	<brief_summary>Primary purpose : Effects of two doses of hormone therapy on hsCRP. The effects of hormone replacement therapy on inflammatory markers are dose-dependent.</brief_summary>
	<brief_title>Dose Effects of Hormone Therapy (Two Doses of Estradiol Associated to Progesterone) on Inflammatory Markers</brief_title>
	<detailed_description>Pro-inflammatory study of the effects in short term of two difference doses of 17beta-estradiol at the menopause woman</detailed_description>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<criteria>Symptomatic menopausal women : &gt;=50 years and amenorrhea &gt;=1 year or &lt;50 years and amenorrhea &gt;=1 year and plasmatic FSH &gt;= 30 UI/l Normal mammography in the last 2 years before inclusion Normal cervical smear in the last 2 years before inclusion Written consent for participation in the study Unconfirmed Menopause with amenorrhoea of less than year Oestrogenprogesterone Treatment anterior in 3 months previous the inclusion Recently a viral Infection or bacteriologic(at least of 2 weeks) Dental Infection Inflammatory Pathology chronicles Antecedent of pathology cancerous with or no a sly hemopathy Addiction to smoking of more than 20 cigarettes a day or an alcoholic consumption furthermore of 4 glasses a day Taken concomitant of one of the treatments forbidden:statine, vitamin B6 or B12, folates, antiinflammatory, anti aggregant Plaquettes, DHEA, phytoestrogens Refusal to sign the assent informed Not membership in a regime about social security</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2005</verification_date>
	<keyword>Hormone</keyword>
	<keyword>Menopause</keyword>
	<keyword>Inflammation</keyword>
	<keyword>Dose effects</keyword>
	<keyword>Apoptosis</keyword>
</DOC>